About: Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.21 (-0.86%)
AUPH NASDAQ Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc share price
Atividade de preço de AUPH
Último preço
$ 17,210
Variação (24h)
-0,15 USD (0,86%)
Volume
744.54K
Volume (média 4 sem.)
-
Abertura
$ 17,44
Variação do dia
$ 17,10 - $ 17,58
Fechamento anterior
$ 17,36
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
AUPH price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals